Found 13 matching trials
Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
PHASE3The purpose of this study is to evaluate the efficacy and safety of tebenta...
Location
Mayo Clinic Arizona
A Study of the Intra-Patient Escalation Dosing Regimen With IMCgp100 in Patients With Advanced Uveal Melanoma
PHASE1IMCgp100-102 is a Phase I/II study of the weekly intra-patient escalation d...
Location
University California, San Diego Moores Cancer Center
A Cohort IND Expanded Access Program for Supporting Patient Access to Tebentafusp
N/AThis Expanded Access Program aims to:
1. Provide access to tebentafusp for...
Location
Multiple Locations
Neoadjuvant Tebentafusp for Uveal Melanoma
PHASE2This is a prospective, single arm, phase II clinical trial of neoadjuvant T...
Location
Sidney Kimmel Cancer Center at Thomas Jefferson University
Adjuvant Tebentafusp in High Risk Ocular Melanoma
PHASE3At least 50% of patients with high-risk primary uveal melanoma will develop...
Location
Northwell Health -Center for Advanced Medicine
Tebentafusp-tebn With LDT in Metastatic UM
PHASE1This study is a multicenter, open label phase I/ II trial to assess the saf...
Location
Thomas Jefferson University
Tebentafusp in Molecular Relapsed Disease (MRD) Melanoma
PHASE2Researchers are trying to find ways to improve the management of people wit...
Status
Active Not Recruiting
Location
Cambridge University Hospitals NHS Foundation Trust (Screening only)
Study to Assess the Tolerability of a Bispecific Targeted Biologic IMCgp100 in Malignant Melanoma
PHASE1IMCgp100 is a new biological therapy designed for the treatment of melanoma...
Location
The Angeles Clinic
Safety and Efficacy of IMCgp100 Versus Investigator Choice in Advanced Uveal Melanoma
PHASE2To evaluate the overall survival of HLA-A\*0201 positive adult patients wit...
Location
UCLA Medical Center
IMCgp100-401 Rollover Study
PHASE2IMCgp100-401 is a rollover study that is designed to provide continued acce...
Location
Memorial Slone Kettering Cancer Center